Surgical treatment of chronic thromboembolic pulmonary hypertension

Authors: Matúš Nižňanský 1;  David Ambrož 2;  Tomáš Prskavec 1;  Pavel Jansa 2;  Jaroslav Lindner 1
Authors‘ workplace: II. chirurgická klinika kardiovaskulární chirurgie 1. LF UK a VFN v Praze 1;  II. interní klinika – klinika kardiologie a angiologie 1. LF UK a VFN v Praze 2
Published in: Vnitř Lék 2019; 65(5): 353-358


Chronic thromboembolic pulmonary hypertension (CTEPH) is a disease characterized by a mean pulmonary artery pressure that exceeds 25 mm Hg and is caused by intraluminal thrombi organisation, stenosis and occlusions of pulmonary artery and its branches and peripheral vascular remodelation. It is a chronic complication of acute pulmonary embolism. The obstruction of pulmonary artery branches increases pulmonary vascular resistance (PVR) and this leads to the right ventricular overload and right-sided heart failure. The treatment of choice is surgical pulmonary endarterectomy (PEA), a procedure that is performed in deep hypothermic cardiac arrest. The only center that specializes into the surgical treatment of patients with CTEPH in the Czech Republic is the Complex Cardiovascular Centre at the General Teaching Hospital in Prague. Between years 2004–2017 there were 314 patients opera­ted (including 50 patients from Slovakia, where this treatment is not available). Patients with peripheral type of CTEPH, who are not indicated for operation and also patients with residual pulmonary hypertension after PEA can be indicated for specific vasodilatation therapy. In indicated cases the treatment may involve the balloon angioplasty or lung transplantation.


balloon angioplasty – chronic thromboembolic pulmonary hypertension – pulmonary endarterectomy – riociguat – surgical technique – treatment options

  1. Kim NH, Delcroix M, Jenkins DP et al. Chronic Thromboembolic Pulmonary Hypertension. J Am Coll Cardiol 2013; 62(25 Suppl): D92-D99. Dostupné z DOI: <>.
  2. Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J 2017; 49(2). pii: 1601792. Dostupné z DOI: <–2016>.
  3. Aschermann M. Nová verze klasifikace plicní hypertenze. Vnitř Lék 2015; 61(5): 387–391.
  4. Galie N, Humbert M, Vachiery JL et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46(6): 903–975. Dostupné z DOI: <–2015>.
  5. Vavera Z. Chronická tromboembolická plicní hypertenze. Vnitř Lék 2015; 61(3): 228–235.
  6. Pepke-Zaba J, Delcroix M, Lang I et al. Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Results From an International Prospective Registry. Circulation 2011; 124(18): 1973–1981. Dostupné z DOI: <>.
  7. Mayer E, Jenkins D, Lindner J et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141(3): 702–710. Dostupné z DOI: <>.
  8. Lindner J, Jansa P. Chronická tromboembolická plicní hypertenze. Maxdorf: Praha 2009. ISBN 978–80–7345–181–3.
  9. Jenkins D, Madani M, Fadel E et al. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2017; 26(143). pii: 160111. Dostupné z DOI: <–2016>.
  10. Madani MM, Jamieson SW. Technical advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg 2006; 18(3): 243–249. Dostupné z DOI: <>.
  11. Pepke-Zaba J, Jansa P, Kim NH et al Chronic thromboembolic pulmonary hypertension: role of medical therapy. Eur Respir J 2013; 41(4): 985–990. Dostupné z DOI: <>.
  12. Ghofrani HA, D‘Armini AM, Grimminger F et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. CHEST-1 Study Group. N Engl J Med 2013; 369(4): 319–329. Dostupné z DOI: <>.
  13. Simonneau G, D’Armini AM, Ghofrani HA et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J; 45(5): 1293–1302. Dostupné z DOI: <>.
  14. Voorburg JA, Cats VM, Buis B et al. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest 1988; 94(6): 1249–1253.
  15. Ogo T. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Curr Opin Pulm Med 2015; 21(5): 425–431. Dostupné z DOI: <>.
  16. Delcroix M, Lang I, Pepke-Zaba J et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry. Circulation 2016; 133(9):859–871. Dostupné z DOI: <>.
  17. Thistlethwaite PA, Madani M, Jamieson SW. Outcomes of pulmonary endarterectomy surgery. Semin Thorac Cardiovasc Surg 2006; 18(3): 257–264. Dostupné z DOI: <>.
  18. Jansa P, Ambrož D, Lindner J. Minulost a současnost problematiky plicní cirkulace ve Všeobecné fakultní nemocnici v Praze. Vnitř Lék 2014; 60(12): 1051–1054.
Diabetology Endocrinology Internal medicine
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account